Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00920010 · ClinicalTrials.gov registry record
S9925: Collecting and Storing Samples From Patients With Lung Cancer
A clinical trial of Lung Cancer, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- 2,264
- Enrollment target
- 20
- Study locations
NCT00920010: Completed study of Lung Cancer, sponsored by SWOG Cancer Research Network.
NCT00920010 is a study of Lung Cancer that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 2,264 participants, above the 930-participant average among 409 other Lung Cancer trials with a reported enrollment target (143% higher). The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00920010, a study of Lung Cancer, has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- 2,264 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Collecting and storing samples of tissue, blood, and sputum from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: The purpose of this study is to collect and store tissue, blood, and sputum samples from patients with lung cancer to be tested in the laboratory.
Conditions Studied
Interventions
- OTHER biologic sample preservation procedure
Study Locations (20)
California
- Kaiser Permanente - Deer Valley - Antioch
- Alta Bates Summit Comprehensive Cancer Center - Berkeley
- Providence Saint Joseph Medical Center - Burbank - Burbank
- Peninsula Medical Center - Burlingame
- East Bay Radiation Oncology Center - Castro Valley
- Eden Medical Center - Castro Valley
- Valley Medical Oncology Consultants - Castro Valley - Castro Valley
- Cancer Care Center at John Muir Health - Concord Campus - Concord
- North Bay Cancer Center - Fairfield
- Kaiser Permanente - Fremont - Fremont
- Valley Medical Oncology - Fremont
- Washington Township Hospital - Fremont
- California Cancer Center - Woodward Park Office - Fresno
Arkansas
- Highlands Oncology Group - Springdale - Bentonville
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center - Fort Smith
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences - Little Rock
Alaska
- Alaska Regional Hospital Cancer Center - Anchorage
- Providence Cancer Center - Anchorage
Alabama
- Providence Cancer Center at Providence Hospital - Mobile
Arizona
- Arizona Cancer Center at University of Arizona Health Sciences Center - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,264 participants |
| Start Date | 2000-09 |
| Est. Completion | 2013-01 |
What the finished NCT00920010 record still lists
NCT00920010 is an observational study that tracks outcomes without assigning an intervention. Its 2,264 participants enrollment target places it among the larger protocols in the corpus, above the 930-participant average among 409 other Lung Cancer trials with a reported enrollment target (143% higher).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which biologic sample preservation procedure is the first listed.
NCT00920010 names 20 study sites across 5 states, led by California, Arkansas, Alaska.
Frequently Asked Questions
What is clinical trial NCT00920010 about?
NCT00920010 is a clinical study titled "S9925: Collecting and Storing Samples From Patients With Lung Cancer". RATIONALE: Collecting and storing samples of tissue, blood, and sputum from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: The purpose of this study is to collect and store tissue, blood, and sputum samples from patients with lung cancer to be t...
What is the current status of trial NCT00920010?
This trial is currently completed. The enrollment target is 2,264 participants. The study started on 2000-09. Estimated completion is 2013-01.
What conditions does trial NCT00920010 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT00920010?
The interventions under investigation include: biologic sample preservation procedure (OTHER).
Who is sponsoring clinical trial NCT00920010?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00920010 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00920010's enrollment target sits among peer trials
2,264 25th of 409 higher than 385 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03968393 · 2,270 participants · Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia